Related Experiment Video
Updated: Mar 20, 2026

Lung Tumor Cell Recruitment Assay
Published on: February 26, 2019
P2 receptors in cancer progression and metastatic spreading
Francesco Di Virgilio1, Simonetta Falzoni1, Anna Lisa Giuliani1
1Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Italy.
Abstract:
Tumor microenvironment is nucleoside and nucleotide rich. Adenosine is a key determinant of the highly immunosuppressive tumor interstitium. Extracellular ATP also affects anti-tumor immunity, albeit its effects on host-tumor interaction are incompletely understood. We give here an overview of recent literature covering the role of nucleotide-selective (P2) plasma membrane receptors in tumor growth and progression. P2 receptors are expressed on both host and cancer cells, where depending on the receptor subtype, the inflammatory infiltrate and the tumor cell type they may drive an anti-tumor response or promote tumor progression. It is anticipated that knowledge of the pharmacology, biochemistry and functional activity of the P2 receptors will allow a better understanding of host-tumor interaction and the development of innovative anti-cancer therapy.
Insights
The tumor microenvironment is rich in nucleosides and nucleotides. Nucleotide-selective P2 receptors on host and cancer cells can either promote anti-tumor immunity or drive tumor progression, offering therapeutic potential.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- The tumor microenvironment (TME) is characterized by high concentrations of nucleosides and nucleotides.
- Adenosine plays a critical role in establishing an immunosuppressive TME.
- Extracellular ATP's influence on anti-tumor immunity and host-tumor interactions requires further elucidation.
Purpose of the Study:
- To review recent literature on the function of nucleotide-selective (P2) plasma membrane receptors in cancer.
- To explore the dual role of P2 receptors in modulating tumor growth and anti-tumor immune responses.
Main Methods:
- Literature review of studies investigating P2 receptor expression and function in the TME.
- Analysis of the impact of different P2 receptor subtypes on host-tumor interactions.
Main Results:
- P2 receptors are expressed on both host immune cells and cancer cells within the TME.
- The specific P2 receptor subtype, inflammatory infiltrate, and tumor cell type dictate whether P2 receptor signaling promotes anti-tumor immunity or tumor progression.
- Evidence suggests P2 receptor activity significantly influences the host-tumor crosstalk.
Conclusions:
- Understanding the pharmacology, biochemistry, and functional roles of P2 receptors is crucial for deciphering host-tumor interactions.
- Targeting P2 receptors presents a promising avenue for developing novel anti-cancer therapies.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Mitogens and the Cell Cycle
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Cancer Cell Migration through Invadopodia

